Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world Study of Idebenone in the Treatment of Leber's Hereditary Optic Neuropathy
ChiCTR2600126672Phase 4Recruiting
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of idebenone in Leber hereditary optic neuropathy (LHON), sponsored by Peking Union Medical College Hospital. Primary endpoint: visual acuity. Started Jun 2026; status: recruiting.
02
Drugs
idebenone
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on ChiCTR2600126672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600126672.